financetom
Business
financetom
/
Business
/
Top Midday Decliners
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Top Midday Decliners
May 14, 2024 11:12 AM

01:55 PM EDT, 05/14/2024 (MT Newswires) -- Akoya Biosciences ( AKYA ) reported late Monday lower Q1 revenue from a year earlier, missing market expectations.

Shares slumped 29.6% following a surge in intraday trading volume to over 1.87 million from a daily average of about 162,000.

Shimmick ( SHIM ) reported a Q1 adjusted loss that more than quadrupled after sales slumped more than forecast.

Shares dropped nearly 28% as intraday trading volume rose to over 174,000 compared with a daily average of about 95,000.

Scorpius Holdings ( SCPX ) said Tuesday it priced an underwritten offering of 60 million units and/or pre-funded units in lieu thereof, targeting gross proceeds of about $6 million.

Shares slumped 55%, with intraday trading volume at over 12.4 million versus a daily average of about 687,000.

Price: 2.90, Change: -1.22, Percent Change: -29.61

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Vail Resorts to Launch $400 Million Senior Notes Offering
Vail Resorts to Launch $400 Million Senior Notes Offering
Jun 30, 2025
09:28 AM EDT, 06/30/2025 (MT Newswires) -- Vail Resorts ( MTN ) said Monday that it plans to launch a private offering of $400 million worth of senior notes due 2030. The ski resort owner said it will use the proceeds to repay borrowings under its revolving credit facility used to fund a $200 million share buyback, and to repurchase...
Tyra Biosciences Doses First Patient in Non-Muscle Invasive Bladder Cancer Trial
Tyra Biosciences Doses First Patient in Non-Muscle Invasive Bladder Cancer Trial
Jun 30, 2025
09:25 AM EDT, 06/30/2025 (MT Newswires) -- Tyra Biosciences ( TYRA ) said Monday the first patient has been dosed in a phase 2 study of TYRA-300 in patients with low-grade, intermediate-risk non-muscle invasive bladder cancer. Patients will receive once-daily doses of TYRA-300, with the primary endpoint being complete response at three months. Secondary endpoints include time to recurrence, the...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
TuHURA Biosciences Closes Kineta Acquisition
TuHURA Biosciences Closes Kineta Acquisition
Jun 30, 2025
09:26 AM EDT, 06/30/2025 (MT Newswires) -- TuHURA Biosciences ( HURA ) said Monday that it has completed its acquisition of Kineta. TuHURA said Kineta shareholders received 2.87 million TuHURA shares and may receive up to 1.13 million additional shares based on post-closing adjustments. They are also eligible for a portion of future cash from legacy Kineta asset sales, TuHURA...
Copyright 2023-2026 - www.financetom.com All Rights Reserved